Bayer to Present New Data for KERENDIA(R) (finerenone) in People with Chronic Kidney Disease and Type 1 or Type 2 Diabetes at American Society of Nephrology (ASN) Kidney Week 2025

Bayer announced today that data from across the KERENDIA (R) (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) ...

Bayer to Present New Data for KERENDIA® (finerenone) in People with Chronic Kidney Disease and Type 1 or Type 2 Diabetes at American Society of Nephrology (ASN) Kidney Week 2025

Bayer announced today that data from across the KERENDIA® (finerenone) comprehensive clinical trial program will be presented in scientific sessions at the American Society of Nephrology (ASN) Kidney ...
Le Lézard

KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease

Bayer today announced new Phase III investigational data from the pivotal FINE-ONE trial showing that KERENDIA® (finerenone) significantly reduced urine albumin-to-creatinine ratio (UACR) from ...
Wall Street Journal

Reporter, The Wall Street Journal

Lane Florsheim is a reporter covering fashion, culture, wellness and other lifestyle topics on The Wall Street Journal's Style News desk in New York. She is a contributor to WSJ. Magazine. Lane also ...
Yahoo Finance

iShares MSCI ACWI ETF (ACWI)

ETF Summary The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially ...